DAWN
HealthcareDay One Biopharmaceuticals, Inc.
$21.30+0.03 (+0.14%)
Prev Close
$21.27
Open
$21.29
High
$21.32
Low
$21.26
Volume
4.55M
Market Cap
$2.20B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Day One Biopharmaceuticals, Inc. (DAWN) has been exclusively selling, with 0 insider purchases totaling $0.00 and 22 insider sales totaling $1.45M. The most recent insider transaction was by Bender Jeremy (director, officer: CHIEF EXECUTIVE OFFICER), who sold $179.3K worth of shares on Feb 18, 2026. Day One Biopharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.20B.
Buys (12M)
0
$0.00
Sells (12M)
22
$1.45M
Net Activity
Net Seller
$1.45M
Active Insiders
5
last 12 mo
DAWN Price Chart
DAWN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026↗ | Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 15,459 | $11.60 | $179.3K | 204,603 |
| Feb 18, 2026↗ | Dubow Adam | officer: Gen Counsel & Secretary | Sell | 6,395 | $11.60 | $74.2K | 72,694 |
| Feb 18, 2026↗ | Merendino Lauren | officer: Chief Commercial Officer | Sell | 5,814 | $11.60 | $67.4K | 60,157 |
| Feb 18, 2026↗ | VASCONCELLES MICHAEL | officer: Head of Research and Dev. | Sell | 2,728 | $11.60 | $31.6K | 4,397 |
| Feb 18, 2026↗ | York Charles N II | officer: COO and CFO | Sell | 6,065 | $11.60 | $70.4K | 312,025 |
| Feb 15, 2026↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 15,459 | $11.60 | $179.3K | 0 |
| Feb 15, 2026↗ | Dubow Adam | Gen Counsel & Secretary | Sell | 6,395 | $11.60 | $74.2K | 0 |
| Feb 15, 2026↗ | Merendino Lauren | Chief Commercial Officer | Sell | 5,814 | $11.60 | $67.4K | 0 |
| Feb 15, 2026↗ | VASCONCELLES MICHAEL | Head of Research and Dev. | Sell | 2,728 | $11.60 | $31.6K | 0 |
| Feb 15, 2026↗ | York Charles N II | COO and CFO | Sell | 6,065 | $11.60 | $70.4K | 0 |
| Nov 15, 2025↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 15,894 | $8.91 | $141.7K | 0 |
| Nov 15, 2025↗ | Dubow Adam | Gen Counsel & Secretary | Sell | 4,319 | $8.91 | $38.5K | 0 |
| Nov 15, 2025↗ | Merendino Lauren | Chief Commercial Officer | Sell | 3,726 | $8.91 | $33.2K | 0 |
| Nov 15, 2025↗ | York Charles N II | COO and CFO | Sell | 4,062 | $8.91 | $36.2K | 0 |
| Aug 15, 2025↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 16,058 | $6.77 | $108.7K | 0 |
| Aug 15, 2025↗ | Dubow Adam | Gen Counsel & Secretary | Sell | 4,365 | $6.77 | $29.5K | 0 |
| Aug 15, 2025↗ | Merendino Lauren | Chief Commercial Officer | Sell | 3,766 | $6.77 | $25.5K | 0 |
| Aug 15, 2025↗ | York Charles N II | COO and CFO | Sell | 4,106 | $6.77 | $27.8K | 0 |
| May 15, 2025↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 13,964 | $6.26 | $87.4K | 0 |
| May 15, 2025↗ | Dubow Adam | GENERAL COUNSEL | Sell | 4,552 | $6.26 | $28.5K | 0 |
| May 15, 2025↗ | Merendino Lauren | Chief Commercial Officer | Sell | 3,927 | $6.26 | $24.6K | 0 |
| May 15, 2025↗ | York Charles N II | COO, CFO AND SECRETARY | Sell | 4,282 | $6.26 | $26.8K | 0 |
| Feb 15, 2025↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 12,048 | $11.96 | $144.1K | 0 |
| Feb 15, 2025↗ | Dubow Adam | GENERAL COUNSEL | Sell | 4,646 | $11.96 | $55.6K | 0 |
| Feb 15, 2025↗ | York Charles N II | COO, CFO AND SECRETARY | Sell | 4,370 | $11.96 | $52.3K | 0 |
| Dec 10, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 30,000 | $13.31 | $399.3K | 0 |
| Nov 15, 2024↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 10,554 | $13.21 | $139.4K | 0 |
| Nov 15, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 2,206 | $13.21 | $29.1K | 0 |
| Nov 15, 2024↗ | Dubow Adam | GENERAL COUNSEL | Sell | 3,165 | $13.21 | $41.8K | 0 |
| Nov 15, 2024↗ | York Charles N II | COO, CFO AND SECRETARY | Sell | 2,602 | $13.21 | $34.4K | 0 |
| Nov 8, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 28,255 | $16.15 | $456.2K | 0 |
| Nov 7, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 11,245 | $16.03 | $180.3K | 0 |
| Oct 31, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 500 | $16.02 | $8.0K | 0 |
| Sep 10, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 30,000 | $14.22 | $426.7K | 0 |
| Aug 15, 2024↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 10,681 | $14.00 | $149.5K | 0 |
| Aug 15, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 2,232 | $14.00 | $31.2K | 0 |
| Aug 15, 2024↗ | Dubow Adam | GENERAL COUNSEL | Sell | 3,202 | $14.00 | $44.8K | 0 |
| Aug 15, 2024↗ | York Charles N II | COO, CFO AND SECRETARY | Sell | 2,633 | $14.00 | $36.9K | 0 |
| Jul 16, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 20,000 | $16.01 | $320.2K | 0 |
| Jun 21, 2024↗ | Ramasastry Saira | Director | Sell | 10,000 | $13.19 | $131.9K | 0 |
| Jun 10, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 30,000 | $12.62 | $378.6K | 0 |
| May 15, 2024↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 7,873 | $16.08 | $126.6K | 0 |
| May 15, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 2,267 | $16.08 | $36.5K | 0 |
| May 15, 2024↗ | Dubow Adam | GENERAL COUNSEL | Sell | 3,253 | $16.08 | $52.3K | 0 |
| May 15, 2024↗ | York Charles N II | COO, CFO AND SECRETARY | Sell | 2,675 | $16.08 | $43.0K | 0 |
| May 10, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 10,000 | $16.37 | $163.7K | 0 |
| May 1, 2024↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 79,211 | $17.87 | $1.42M | 0 |
| May 1, 2024↗ | York Charles N II | COO, CFO AND SECRETARY | Sell | 60,461 | $17.88 | $1.08M | 0 |
| Apr 18, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 10,000 | $16.02 | $160.2K | 0 |
| Mar 25, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 10,000 | $16.01 | $160.1K | 0 |
| Mar 11, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 30,000 | $15.24 | $457.3K | 0 |
| Feb 27, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 20,000 | $16.11 | $322.2K | 0 |
| Feb 15, 2024↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 7,615 | $15.25 | $116.1K | 0 |
| Feb 15, 2024↗ | Blackman Samuel C. | HEAD OF RESEARCH AND DEVELOPME | Sell | 2,258 | $15.25 | $34.4K | 0 |
| Feb 15, 2024↗ | Dubow Adam | GENERAL COUNSEL | Sell | 3,242 | $15.25 | $49.4K | 0 |
| Feb 15, 2024↗ | York Charles N II | COO, CFO AND SECRETARY | Sell | 2,666 | $15.25 | $40.7K | 0 |
| Nov 15, 2023↗ | Bender Jeremy | Chief Executive Officer | Sell | 3,107 | $11.69 | $36.3K | 0 |
| Nov 15, 2023↗ | Blackman Samuel C. | Head of Research and Developme | Sell | 709 | $11.69 | $8.3K | 0 |
| Nov 15, 2023↗ | Dubow Adam | General Counsel | Sell | 5,313 | $11.69 | $62.1K | 0 |
| Nov 15, 2023↗ | York Charles N II | COO, CFO and Secretary | Sell | 956 | $11.69 | $11.2K | 0 |
| Aug 15, 2023↗ | Bender Jeremy | Chief Executive Officer | Sell | 2,996 | $13.86 | $41.5K | 0 |
| Aug 15, 2023↗ | Blackman Samuel C. | Head of Research and Developme | Sell | 668 | $13.86 | $9.3K | 0 |
| Aug 15, 2023↗ | York Charles N II | COO, CFO and Secretary | Sell | 922 | $13.86 | $12.8K | 0 |
| Jun 5, 2023↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 1,229 | $16.00 | $19.7K | 0 |
| May 15, 2023↗ | Bender Jeremy | Chief Executive Officer | Sell | 3,104 | $13.12 | $40.7K | 0 |
| May 15, 2023↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 692 | $13.12 | $9.1K | 0 |
| May 15, 2023↗ | York Charles N II | COO, CFO and Secretary | Sell | 955 | $13.12 | $12.5K | 0 |
| Mar 10, 2023↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $18.05 | $180.5K | 0 |
| Mar 7, 2023↗ | Bender Jeremy | Chief Executive Officer | Sell | 12,500 | $20.01 | $250.1K | 0 |
| Mar 1, 2023↗ | Grant Julie Papanek | Director | Sell | 25,000 | $18.61 | $465.3K | 0 |
| Feb 17, 2023↗ | York Charles N II | COO, CFO and Secretary | Sell | 9,377 | $20.03 | $187.8K | 0 |
| Feb 15, 2023↗ | Bender Jeremy | Chief Executive Officer | Sell | 3,022 | $19.57 | $59.1K | 0 |
| Feb 15, 2023↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 674 | $19.57 | $13.2K | 0 |
| Feb 15, 2023↗ | York Charles N II | COO, CFO and Secretary | Sell | 930 | $19.57 | $18.2K | 0 |
| Feb 10, 2023↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $20.07 | $200.7K | 0 |
| Feb 1, 2023↗ | Grant Julie Papanek | Director | Sell | 25,000 | $21.23 | $530.8K | 0 |
| Jan 23, 2023↗ | Bender Jeremy | Chief Executive Officer | Sell | 12,500 | $22.00 | $275.0K | 0 |
| Jan 20, 2023↗ | York Charles N II | COO, CFO and Secretary | Sell | 10,000 | $22.75 | $227.5K | 0 |
| Jan 10, 2023↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $22.86 | $228.6K | 0 |
| Jan 3, 2023↗ | Grant Julie Papanek | Director | Sell | 25,000 | $20.65 | $516.1K | 0 |
| Dec 21, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 12,500 | $20.32 | $254.0K | 0 |
| Dec 20, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 10,000 | $20.07 | $200.7K | 0 |
| Dec 8, 2022↗ | Grant Julie Papanek | Director | Sell | 4,358 | $22.08 | $96.2K | 0 |
| Dec 1, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $21.45 | $214.5K | 0 |
| Dec 1, 2022↗ | Grant Julie Papanek | Director | Sell | 10,000 | $21.65 | $216.5K | 0 |
| Nov 21, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 12,500 | $20.76 | $259.5K | 0 |
| Nov 21, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 10,000 | $20.76 | $207.6K | 0 |
| Nov 15, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 1,513 | $21.46 | $32.5K | 0 |
| Nov 15, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 377 | $21.46 | $8.1K | 0 |
| Nov 15, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 430 | $21.46 | $9.2K | 0 |
| Nov 1, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 12,500 | $20.03 | $250.4K | 0 |
| Nov 1, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $20.01 | $200.1K | 0 |
| Nov 1, 2022↗ | Grant Julie Papanek | Director | Sell | 10,000 | $20.03 | $200.3K | 0 |
| Nov 1, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 10,000 | $20.03 | $200.3K | 0 |
| Oct 3, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 12,500 | $20.05 | $250.6K | 0 |
| Oct 3, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $19.99 | $199.9K | 0 |
| Oct 3, 2022↗ | Grant Julie Papanek | Director | Sell | 10,000 | $20.03 | $200.3K | 0 |
| Oct 3, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 10,000 | $20.05 | $200.5K | 0 |
| Sep 21, 2022↗ | Grant Julie Papanek | Director | Sell | 613,603 | $18.55 | $11.38M | 0 |
| Sep 16, 2022↗ | Grant Julie Papanek | Director | Sell | 340,702 | $20.44 | $6.96M | 0 |
| Sep 13, 2022↗ | Grant Julie Papanek | Director | Sell | 245,039 | $23.76 | $5.82M | 0 |
| Sep 2, 2022↗ | Grant Papanek Julie | Director | Sell | 5,000 | $23.82 | $119.1K | 0 |
| Sep 1, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 25,000 | $23.25 | $581.2K | 0 |
| Sep 1, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $23.25 | $232.5K | 0 |
| Sep 1, 2022↗ | Grant Papanek Julie | Director | Sell | 5,000 | $23.27 | $116.4K | 0 |
| Sep 1, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 10,000 | $23.25 | $232.5K | 0 |
| Aug 15, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 4,003 | $24.31 | $97.3K | 0 |
| Aug 15, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 941 | $24.31 | $22.9K | 0 |
| Aug 15, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 1,089 | $24.31 | $26.5K | 0 |
| Aug 4, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 12,500 | $20.00 | $250.0K | 0 |
| Aug 4, 2022↗ | Grant Papanek Julie | Director | Sell | 10,000 | $20.00 | $200.0K | 0 |
| Aug 4, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 10,000 | $20.05 | $200.5K | 0 |
| Aug 1, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $16.88 | $168.8K | 0 |
| Jul 18, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 2,600 | $20.00 | $52.0K | 0 |
| Jul 18, 2022↗ | Grant Papanek Julie | Director | Sell | 2,600 | $20.00 | $52.0K | 0 |
| Jul 18, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 2,500 | $20.00 | $50.0K | 0 |
| Jul 8, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 1,795 | $20.00 | $35.9K | 0 |
| Jul 8, 2022↗ | Grant Papanek Julie | Director | Sell | 1,242 | $20.00 | $24.8K | 0 |
| Jul 8, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 1,416 | $20.00 | $28.3K | 0 |
| Jul 1, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 2,603 | $20.00 | $52.1K | 0 |
| Jul 1, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $18.72 | $187.2K | 0 |
| Jul 1, 2022↗ | Grant Papanek Julie | Director | Sell | 1,800 | $20.00 | $36.0K | 0 |
| Jul 1, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 2,279 | $20.00 | $45.6K | 0 |
| Jun 17, 2022↗ | Gladstone Michael | Director | Buy | 766,667 | $15.00 | $11.50M | 0 |
| Jun 15, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 50,000 | $16.26 | $813.2K | 0 |
| Jan 3, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $17.10 | $171.0K | 0 |
| Dec 1, 2021↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $17.22 | $172.2K | 0 |
| Jun 1, 2021↗ | Becker Daniel J. | Director | Buy | 5,000 | $16.00 | $80.0K | 0 |
| Jun 1, 2021↗ | Josey John A. | Director | Buy | 7,000 | $16.00 | $112.0K | 0 |
| Feb 1, 2021↗ | Grant Papanek Julie | Director | Buy | 13,000 | $16.00 | $208.0K | 0 |
DAWN Insider Buying Activity
The following table shows recent insider purchases of Day One Biopharmaceuticals, Inc. (DAWN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 17, 2022↗ | Gladstone Michael | Director | Buy | 766,667 | $15.00 | $11.50M | 0 |
| Jun 1, 2021↗ | Becker Daniel J. | Director | Buy | 5,000 | $16.00 | $80.0K | 0 |
| Jun 1, 2021↗ | Josey John A. | Director | Buy | 7,000 | $16.00 | $112.0K | 0 |
| Feb 1, 2021↗ | Grant Papanek Julie | Director | Buy | 13,000 | $16.00 | $208.0K | 0 |
DAWN Insider Selling Activity
The following table shows recent insider sales of Day One Biopharmaceuticals, Inc. (DAWN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026↗ | Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 15,459 | $11.60 | $179.3K | 204,603 |
| Feb 18, 2026↗ | Dubow Adam | officer: Gen Counsel & Secretary | Sell | 6,395 | $11.60 | $74.2K | 72,694 |
| Feb 18, 2026↗ | Merendino Lauren | officer: Chief Commercial Officer | Sell | 5,814 | $11.60 | $67.4K | 60,157 |
| Feb 18, 2026↗ | VASCONCELLES MICHAEL | officer: Head of Research and Dev. | Sell | 2,728 | $11.60 | $31.6K | 4,397 |
| Feb 18, 2026↗ | York Charles N II | officer: COO and CFO | Sell | 6,065 | $11.60 | $70.4K | 312,025 |
| Feb 15, 2026↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 15,459 | $11.60 | $179.3K | 0 |
| Feb 15, 2026↗ | Dubow Adam | Gen Counsel & Secretary | Sell | 6,395 | $11.60 | $74.2K | 0 |
| Feb 15, 2026↗ | Merendino Lauren | Chief Commercial Officer | Sell | 5,814 | $11.60 | $67.4K | 0 |
| Feb 15, 2026↗ | VASCONCELLES MICHAEL | Head of Research and Dev. | Sell | 2,728 | $11.60 | $31.6K | 0 |
| Feb 15, 2026↗ | York Charles N II | COO and CFO | Sell | 6,065 | $11.60 | $70.4K | 0 |
| Nov 15, 2025↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 15,894 | $8.91 | $141.7K | 0 |
| Nov 15, 2025↗ | Dubow Adam | Gen Counsel & Secretary | Sell | 4,319 | $8.91 | $38.5K | 0 |
| Nov 15, 2025↗ | Merendino Lauren | Chief Commercial Officer | Sell | 3,726 | $8.91 | $33.2K | 0 |
| Nov 15, 2025↗ | York Charles N II | COO and CFO | Sell | 4,062 | $8.91 | $36.2K | 0 |
| Aug 15, 2025↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 16,058 | $6.77 | $108.7K | 0 |
| Aug 15, 2025↗ | Dubow Adam | Gen Counsel & Secretary | Sell | 4,365 | $6.77 | $29.5K | 0 |
| Aug 15, 2025↗ | Merendino Lauren | Chief Commercial Officer | Sell | 3,766 | $6.77 | $25.5K | 0 |
| Aug 15, 2025↗ | York Charles N II | COO and CFO | Sell | 4,106 | $6.77 | $27.8K | 0 |
| May 15, 2025↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 13,964 | $6.26 | $87.4K | 0 |
| May 15, 2025↗ | Dubow Adam | GENERAL COUNSEL | Sell | 4,552 | $6.26 | $28.5K | 0 |
| May 15, 2025↗ | Merendino Lauren | Chief Commercial Officer | Sell | 3,927 | $6.26 | $24.6K | 0 |
| May 15, 2025↗ | York Charles N II | COO, CFO AND SECRETARY | Sell | 4,282 | $6.26 | $26.8K | 0 |
| Feb 15, 2025↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 12,048 | $11.96 | $144.1K | 0 |
| Feb 15, 2025↗ | Dubow Adam | GENERAL COUNSEL | Sell | 4,646 | $11.96 | $55.6K | 0 |
| Feb 15, 2025↗ | York Charles N II | COO, CFO AND SECRETARY | Sell | 4,370 | $11.96 | $52.3K | 0 |
| Dec 10, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 30,000 | $13.31 | $399.3K | 0 |
| Nov 15, 2024↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 10,554 | $13.21 | $139.4K | 0 |
| Nov 15, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 2,206 | $13.21 | $29.1K | 0 |
| Nov 15, 2024↗ | Dubow Adam | GENERAL COUNSEL | Sell | 3,165 | $13.21 | $41.8K | 0 |
| Nov 15, 2024↗ | York Charles N II | COO, CFO AND SECRETARY | Sell | 2,602 | $13.21 | $34.4K | 0 |
| Nov 8, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 28,255 | $16.15 | $456.2K | 0 |
| Nov 7, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 11,245 | $16.03 | $180.3K | 0 |
| Oct 31, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 500 | $16.02 | $8.0K | 0 |
| Sep 10, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 30,000 | $14.22 | $426.7K | 0 |
| Aug 15, 2024↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 10,681 | $14.00 | $149.5K | 0 |
| Aug 15, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 2,232 | $14.00 | $31.2K | 0 |
| Aug 15, 2024↗ | Dubow Adam | GENERAL COUNSEL | Sell | 3,202 | $14.00 | $44.8K | 0 |
| Aug 15, 2024↗ | York Charles N II | COO, CFO AND SECRETARY | Sell | 2,633 | $14.00 | $36.9K | 0 |
| Jul 16, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 20,000 | $16.01 | $320.2K | 0 |
| Jun 21, 2024↗ | Ramasastry Saira | Director | Sell | 10,000 | $13.19 | $131.9K | 0 |
| Jun 10, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 30,000 | $12.62 | $378.6K | 0 |
| May 15, 2024↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 7,873 | $16.08 | $126.6K | 0 |
| May 15, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 2,267 | $16.08 | $36.5K | 0 |
| May 15, 2024↗ | Dubow Adam | GENERAL COUNSEL | Sell | 3,253 | $16.08 | $52.3K | 0 |
| May 15, 2024↗ | York Charles N II | COO, CFO AND SECRETARY | Sell | 2,675 | $16.08 | $43.0K | 0 |
| May 10, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 10,000 | $16.37 | $163.7K | 0 |
| May 1, 2024↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 79,211 | $17.87 | $1.42M | 0 |
| May 1, 2024↗ | York Charles N II | COO, CFO AND SECRETARY | Sell | 60,461 | $17.88 | $1.08M | 0 |
| Apr 18, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 10,000 | $16.02 | $160.2K | 0 |
| Mar 25, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 10,000 | $16.01 | $160.1K | 0 |
| Mar 11, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 30,000 | $15.24 | $457.3K | 0 |
| Feb 27, 2024↗ | Blackman Samuel C. | HEAD OF R&D | Sell | 20,000 | $16.11 | $322.2K | 0 |
| Feb 15, 2024↗ | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | 7,615 | $15.25 | $116.1K | 0 |
| Feb 15, 2024↗ | Blackman Samuel C. | HEAD OF RESEARCH AND DEVELOPME | Sell | 2,258 | $15.25 | $34.4K | 0 |
| Feb 15, 2024↗ | Dubow Adam | GENERAL COUNSEL | Sell | 3,242 | $15.25 | $49.4K | 0 |
| Feb 15, 2024↗ | York Charles N II | COO, CFO AND SECRETARY | Sell | 2,666 | $15.25 | $40.7K | 0 |
| Nov 15, 2023↗ | Bender Jeremy | Chief Executive Officer | Sell | 3,107 | $11.69 | $36.3K | 0 |
| Nov 15, 2023↗ | Blackman Samuel C. | Head of Research and Developme | Sell | 709 | $11.69 | $8.3K | 0 |
| Nov 15, 2023↗ | Dubow Adam | General Counsel | Sell | 5,313 | $11.69 | $62.1K | 0 |
| Nov 15, 2023↗ | York Charles N II | COO, CFO and Secretary | Sell | 956 | $11.69 | $11.2K | 0 |
| Aug 15, 2023↗ | Bender Jeremy | Chief Executive Officer | Sell | 2,996 | $13.86 | $41.5K | 0 |
| Aug 15, 2023↗ | Blackman Samuel C. | Head of Research and Developme | Sell | 668 | $13.86 | $9.3K | 0 |
| Aug 15, 2023↗ | York Charles N II | COO, CFO and Secretary | Sell | 922 | $13.86 | $12.8K | 0 |
| Jun 5, 2023↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 1,229 | $16.00 | $19.7K | 0 |
| May 15, 2023↗ | Bender Jeremy | Chief Executive Officer | Sell | 3,104 | $13.12 | $40.7K | 0 |
| May 15, 2023↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 692 | $13.12 | $9.1K | 0 |
| May 15, 2023↗ | York Charles N II | COO, CFO and Secretary | Sell | 955 | $13.12 | $12.5K | 0 |
| Mar 10, 2023↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $18.05 | $180.5K | 0 |
| Mar 7, 2023↗ | Bender Jeremy | Chief Executive Officer | Sell | 12,500 | $20.01 | $250.1K | 0 |
| Mar 1, 2023↗ | Grant Julie Papanek | Director | Sell | 25,000 | $18.61 | $465.3K | 0 |
| Feb 17, 2023↗ | York Charles N II | COO, CFO and Secretary | Sell | 9,377 | $20.03 | $187.8K | 0 |
| Feb 15, 2023↗ | Bender Jeremy | Chief Executive Officer | Sell | 3,022 | $19.57 | $59.1K | 0 |
| Feb 15, 2023↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 674 | $19.57 | $13.2K | 0 |
| Feb 15, 2023↗ | York Charles N II | COO, CFO and Secretary | Sell | 930 | $19.57 | $18.2K | 0 |
| Feb 10, 2023↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $20.07 | $200.7K | 0 |
| Feb 1, 2023↗ | Grant Julie Papanek | Director | Sell | 25,000 | $21.23 | $530.8K | 0 |
| Jan 23, 2023↗ | Bender Jeremy | Chief Executive Officer | Sell | 12,500 | $22.00 | $275.0K | 0 |
| Jan 20, 2023↗ | York Charles N II | COO, CFO and Secretary | Sell | 10,000 | $22.75 | $227.5K | 0 |
| Jan 10, 2023↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $22.86 | $228.6K | 0 |
| Jan 3, 2023↗ | Grant Julie Papanek | Director | Sell | 25,000 | $20.65 | $516.1K | 0 |
| Dec 21, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 12,500 | $20.32 | $254.0K | 0 |
| Dec 20, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 10,000 | $20.07 | $200.7K | 0 |
| Dec 8, 2022↗ | Grant Julie Papanek | Director | Sell | 4,358 | $22.08 | $96.2K | 0 |
| Dec 1, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $21.45 | $214.5K | 0 |
| Dec 1, 2022↗ | Grant Julie Papanek | Director | Sell | 10,000 | $21.65 | $216.5K | 0 |
| Nov 21, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 12,500 | $20.76 | $259.5K | 0 |
| Nov 21, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 10,000 | $20.76 | $207.6K | 0 |
| Nov 15, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 1,513 | $21.46 | $32.5K | 0 |
| Nov 15, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 377 | $21.46 | $8.1K | 0 |
| Nov 15, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 430 | $21.46 | $9.2K | 0 |
| Nov 1, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 12,500 | $20.03 | $250.4K | 0 |
| Nov 1, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $20.01 | $200.1K | 0 |
| Nov 1, 2022↗ | Grant Julie Papanek | Director | Sell | 10,000 | $20.03 | $200.3K | 0 |
| Nov 1, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 10,000 | $20.03 | $200.3K | 0 |
| Oct 3, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 12,500 | $20.05 | $250.6K | 0 |
| Oct 3, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $19.99 | $199.9K | 0 |
| Oct 3, 2022↗ | Grant Julie Papanek | Director | Sell | 10,000 | $20.03 | $200.3K | 0 |
| Oct 3, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 10,000 | $20.05 | $200.5K | 0 |
| Sep 21, 2022↗ | Grant Julie Papanek | Director | Sell | 613,603 | $18.55 | $11.38M | 0 |
| Sep 16, 2022↗ | Grant Julie Papanek | Director | Sell | 340,702 | $20.44 | $6.96M | 0 |
| Sep 13, 2022↗ | Grant Julie Papanek | Director | Sell | 245,039 | $23.76 | $5.82M | 0 |
| Sep 2, 2022↗ | Grant Papanek Julie | Director | Sell | 5,000 | $23.82 | $119.1K | 0 |
| Sep 1, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 25,000 | $23.25 | $581.2K | 0 |
| Sep 1, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $23.25 | $232.5K | 0 |
| Sep 1, 2022↗ | Grant Papanek Julie | Director | Sell | 5,000 | $23.27 | $116.4K | 0 |
| Sep 1, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 10,000 | $23.25 | $232.5K | 0 |
| Aug 15, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 4,003 | $24.31 | $97.3K | 0 |
| Aug 15, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 941 | $24.31 | $22.9K | 0 |
| Aug 15, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 1,089 | $24.31 | $26.5K | 0 |
| Aug 4, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 12,500 | $20.00 | $250.0K | 0 |
| Aug 4, 2022↗ | Grant Papanek Julie | Director | Sell | 10,000 | $20.00 | $200.0K | 0 |
| Aug 4, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 10,000 | $20.05 | $200.5K | 0 |
| Aug 1, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $16.88 | $168.8K | 0 |
| Jul 18, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 2,600 | $20.00 | $52.0K | 0 |
| Jul 18, 2022↗ | Grant Papanek Julie | Director | Sell | 2,600 | $20.00 | $52.0K | 0 |
| Jul 18, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 2,500 | $20.00 | $50.0K | 0 |
| Jul 8, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 1,795 | $20.00 | $35.9K | 0 |
| Jul 8, 2022↗ | Grant Papanek Julie | Director | Sell | 1,242 | $20.00 | $24.8K | 0 |
| Jul 8, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 1,416 | $20.00 | $28.3K | 0 |
| Jul 1, 2022↗ | Bender Jeremy | Chief Executive Officer | Sell | 2,603 | $20.00 | $52.1K | 0 |
| Jul 1, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $18.72 | $187.2K | 0 |
| Jul 1, 2022↗ | Grant Papanek Julie | Director | Sell | 1,800 | $20.00 | $36.0K | 0 |
| Jul 1, 2022↗ | York Charles N II | COO, CFO and Secretary | Sell | 2,279 | $20.00 | $45.6K | 0 |
| Jun 15, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 50,000 | $16.26 | $813.2K | 0 |
| Jan 3, 2022↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $17.10 | $171.0K | 0 |
| Dec 1, 2021↗ | Blackman Samuel C. | Chief Medical Officer | Sell | 10,000 | $17.22 | $172.2K | 0 |
DAWN Insiders
Similar Stocks to DAWN
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B